ReviewGynecologic oncology2021
It's time to re-evaluate cervical Cancer screening after age 65.
Review in Gynecologic oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06431724 (A Prospective Analysis of Adherence to National Cervical Cancer Screening Recommendations in Women Age >65), which is not on this map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Prospective Analysis of Adherence to National Cervical Cancer Screening Recommendations in Women Age >65
Who cites it
24 citing papers in PubMed, 37 citations in OpenAlex.
- Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study.PLoS medicine · 2023Trial
- Pap testing and high-risk HPV testing for women aged 65 years and older with surgical pathology follow-up.Cancer cytopathology · 2026Article
- Reduced age-wise disparity in estimated cervical cancer screening participation rates after applying hysterectomy correction: a population-based cross-sectional study.BMC women's health · 2026Article
- Treatment Patterns and Prognosis of Cervical Cancer Patients Aged 65 and Older: A Population-Based Cohort Study.Annals of surgical oncology · 2026Article
- Cervical cancer screening and prevalence among older US Medicare beneficiaries with and without HIV.International journal of cancer · 2026Article
- Population-based epidemiological study of cervical cancer in Khuzestan province, Iran (2014-2019).BMC public health · 2026Article
- Age distribution of high-risk HPV infection and cervical lesions in an unvaccinated adult Brazilian population within an organized screening program.Scientific reports · 2026Article
- Survival by Treatment Recommendation and Receipt Among Older Patients With Early-Stage Cervical Cancer.JAMA network open · 2025Article
- Assessing high-risk human papillomavirus-based cervical precancer screening recommendations and implications among women aged 60/65 years and older in Ghana.Scientific reports · 2025Article
- Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA Testing.Journal of medical virology · 2025Article
- Cervical Cancer Screening After Menopause.Healthcare (Basel, Switzerland) · 2025Article
- Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening.JAMA network open · 2025Article
- The potential impact of ACOG guideline changes on genital melanoma detection rates in females: a retrospective cross-sectional analysis and implications for clinical practice.Archives of dermatological research · 2025Article
- Global trend of cervical cancer among women aged 55 and older from 2010 to 2019: An analysis by socio-demographic index and geographic regions.Aging medicine (Milton (N.S.W)) · 2024Article
- Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health Record.O&G open · 2024Article
- The impact of adjusting for hysterectomy prevalence on cervical cancer incidence rates and trends among women aged 30 years or older-United States, 2001-2019.American journal of epidemiology · 2024Article
- Do age-based discontinuation recommendations influence cervical cancer screening rates? Evidence from the United States' Behavioral Risk Factor Surveillance System, 2016 and 2018.Preventive medicine · 2023Article
- A Clinical Prediction Model of Overall Survival for Patients with Cervical Cancer Aged 25-69 Years.Medicina (Kaunas, Lithuania) · 2023Article
- Developing a Tuned Three-Layer Perceptron Fed with Trained Deep Convolutional Neural Networks for Cervical Cancer Diagnosis.Diagnostics (Basel, Switzerland) · 2023Article
- Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
Cervical cancer screening guidelines currently recommend cessation of cervical cancer screening after age 65, despite 20% of new cervical cancer cases occurring in this age group. The US population is aging, research methodology that examines cervical cancer incidence and mortality rates has changed, and sexual behaviors and the rates at which women have hysterectomies have changed over time. Current guidelines do not adequately address these changes, and may be missing significant opportunities to prevent cervical cancer cases and deaths in older women. Furthermore, racial disparities in cervical cancer outcomes may be exacerbated by not addressing the preventive health needs of older women through cervical cancer screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.